13-Apr-2013
The much-hyped bilateral trade and investment agreement (BTIA) between India and the European Union (EU) would not impact the Indian generic drugs industry or lead to a change in the country’s patent law, João Cravinho, EU ambassador to India, said on Friday.
11-Apr-2013
Firstpost
A large number of people living with HIV, cancer patients and health activists took to the streets of Delhi today asking government of India not to sign a Free Trade Agreement (FTA) with the European Union (EU) as it would be detrimental to the interests of tens of thousands of people like them in the country.
10-Apr-2013
Infojustice
We, Cambodian garment workers, sex workers, entertainment workers, people living with HIV, LGBTs, university students, feminists and human right activists from different networks and organisations came together to express our concern about the threat posed by the forthcoming EU-India free trade agreement to the lives of millions of people in Cambodia and many other developing countries across the world.
9-Apr-2013
Around 2000 people including people living with HIV (PLHIV), patient groups and public health activists will take to the streets and rally from Barakhamba road to Jantar Mantar at 11.00 am on 10 April 2013 to voice concerns and protest against harmful provisions being pushed by the EU-India FTA negotiations
2-Apr-2013
First Post
Will Manmohan Singh understand the clear purpose behind the national sentiment around the Supreme Court judgment on Novartis’ cancer drug Glivec? If he does, he should take a relook at the India-EU Free Trade Agreement that is cooking in his back-room.
1-Apr-2013
LiveMint
The gains accruing to the Indian generic drugs industry as a result of the Supreme Court judgement on the Novartis case may be lost if India accepts demands by the European Union (EU) under the proposed free trade agreement (FTA) between the two sides.
27-Mar-2013
Drugmakers and healthcare activists are worried that the India-European Union Free Trade Agreement (FTA), which is in the works, may contain a provision that could imperil local industry and have urged the government to keep patent infringement issues out of FTAs.
21-Mar-2013
The free trade agreement that European Union is pushing India to sign could put an end to India’s status as the pharmacy of the developing providing affordable medicines, especially HIV drugs to countries like Brazil, Thailand, South Africa, Zimbabwe and several others. The negotiations with EU are on at a feverish pace this week in Brussels even before the parliamentary standing committee looking into the free trade agreements (FTAs) has submitted its report.
12-Mar-2013
New Medical
The TPP negotiators are making decisions that will affect at least 600 million people, and potentially hundreds of millions more, in complete secrecy, and this is unacceptable.
6-Mar-2013
Health Action International Europe, Oxfam and Action against AIDS Germany have serious concerns over the repercussions the EU-Thailand FTA will have on access to medicines in Thailand and the region.
5-Mar-2013
MSF
As closed-door talks for the Trans-Pacific Partnership Agreement resume in Singapore this week, international medical humanitarian organization Médecins Sans Frontières calls on the US government to end its stall tactics and revise its proposals for what otherwise promises to be the most harmful trade deal ever for access to medicines in developing countries.
30-Dec-2012
IPS
Days before leaders of the European Union arrived in Norway to collect this year’s Nobel Peace prize, Thai public health activists sent a letter to the northern powerhouse, warning that the EU’s 2012 accolades face a credibility test in this Southeast Asian country.
16-Nov-2012
The Hook
As free trade talks with the European Union reach the endgame, Ottawa is signalling it is prepared to give the Europeans at least part of what they asked for on drug patents — a move that could cost Canadians up to $900 million a year.
15-Nov-2012
A concession on drug patents in a free trade deal with the European Union stands to cost Nova Scotians millions, Health and Wellness Minister David Wilson said Wednesday.
22-Oct-2012
AITEC
Civil society statement calling fpr rejection of the Conformity Assessment and Acceptance of Industrial Products protocol attached to the European Union-Israel Association Agreement
27-Sep-2012
iPolitics
Although the EU is asking Canada to change its patent regime, it is not possible to do so just for the EU. The actual beneficiaries would be all of the world’s brand-name companies. Of the world’s top 12 health care companies by revenue only three or four are resident in the EU.
22-Sep-2012
People afflicted with the Aids virus have called on the government to proceed carefully on free-trade negotiations with the European Union, as the latter’s demands for copyright protection could make it difficult for patients to access cheap medicines.
6-Sep-2012
Nature
Some countries whose governments purchase drugs with a set budget are also alarmed by signs that the TPP may grant new negotiating powers to the industry.
2-Sep-2012
India has asked Japan to remove all non-tax barriers to help the domestic industry take advantage of the comprehensive free-trade agreement and increase share in the Japanese market.
30-Aug-2012
Infojustice
The letter warns that the TRIPS-Plus provisions in the trade agreement between EU and Thailand – including border measures, data exclusivity, patent term extensions, and protection for new indications – would block access to generic medicines.
